Biochemistry, Genetics and Molecular Biology
Fenofibrate
100%
Lipid
95%
Association
76%
Genetics
75%
Triglyceride
58%
Nested Gene
58%
Allele
44%
Single-Nucleotide Polymorphism
43%
Cholesterol
41%
Genotyping
30%
Genetic Divergence
29%
Lipoprotein
28%
High-Density Lipoprotein
20%
Apolipoprotein
20%
Fat
18%
Blood Lipids
17%
Phenotype
17%
Genome-Wide Association Study
16%
Sequencing
16%
Age
16%
Polyunsaturated Fatty Acid
15%
Triacylglycerol Blood Level
13%
Particle Size
13%
Metabolic Pathway
13%
Human
12%
Prevalence
11%
Protein
10%
CYP2D6
10%
Lipid Level
10%
Sample
10%
Monounsaturated Fatty Acid
10%
Gene Polymorphism
10%
Exome
10%
Homozygote
9%
Electric Potential
8%
Insulin Resistance
8%
Cholesterol Blood Level
8%
Mutation
8%
Acetylation
7%
C-Reactive Protein
7%
Single Nucleotide Polymorphism
7%
DNA
7%
Dyslipidemia
6%
Lipid Metabolism
6%
Liquid
6%
Interleukin 6
6%
Metabolite
6%
Glucuronosyltransferase
6%
Glucuronidation
6%
Low-Density Lipoprotein
6%
Medicine and Dentistry
Patient
30%
Therapeutic Procedure
26%
Health Care Cost
22%
Lipid
21%
Triacylglycerol
21%
Association
20%
Hypolipidemic Agent
19%
Diet
19%
Plasma
17%
Adult
16%
Serositis
15%
Managed Care
15%
Cardiovascular System
14%
Gene
13%
Gout
13%
Diabetes
11%
Genome Wide Association Study
11%
Age
11%
Cholesterol
11%
High Density Lipoprotein Cholesterol
11%
Prevalence
10%
Health Disparity
10%
Single Nucleotide Polymorphism
10%
Inpatient
10%
Obesity
10%
Bile Acid
10%
Acetylsalicylic Acid
10%
Fenofibrate
10%
Analysis
9%
Family
8%
Diabetes Mellitus
8%
Serum
7%
Personalized Medicine
7%
Low Density Lipoprotein Cholesterol
7%
Combination Therapy
7%
Drug Therapy
7%
Primary Prevention
6%
C Reactive Protein
6%
Follow up
6%
Maturity Onset Diabetes of the Young
6%
Blood
6%
Metabolism
6%
Adverse Event
6%
Pharmacogenomics
6%
Cardiovascular Risk
6%
Biological Marker
6%
Cardiovascular Disease
5%
Insulin Resistance
5%
Genetic Variability
5%
Marker
5%
Pharmacology, Toxicology and Pharmaceutical Science
Fenofibrate
26%
Pharmacokinetics
23%
Prevalence
20%
Propranolol
20%
Triacylglycerol
16%
Drug
15%
Ischemic Heart Disease
15%
Pharmacogenetics
14%
Gout
13%
CYP2D6
10%
Hyperuricemia
10%
Isosorbide Dinitrate
10%
Antihypertensive Agent
10%
High Performance Liquid Chromatography
10%
Fat
9%
Pharmacodynamics
9%
Hypertension
8%
Allopurinol
8%
Antilipemic Agent
7%
Dextromethorphan
7%
SLCO1B1
6%
Glucuronosyltransferase
6%
Metabolic Syndrome X
6%
Base
5%
Glucuronide
5%
Normal Human
5%
Low Density Lipoprotein Cholesterol
5%
Pharmaceutical Therapy
5%
Cholestasis
5%
Dextrorphan
5%
Pharmacogenomics
5%
Adverse Event
5%
Metoprolol
5%
Debrisoquine
5%
Mixture Model
5%
Bile Acid
5%
Methadone
5%
Pharmacodynamic Modeling
5%
Very Low Density Lipoprotein
5%
Heart Disease
5%
Morbidity
5%
Erythromycin Lactobionate
5%
5 Acetamido 6 Formylamino 3 Methyluracil
5%
Biological Marker
5%
C Reactive Protein
5%
Mortality
5%
Hypercholesterolemia
5%
Oxypurinol
5%
